![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Shuvo Roy | |
---|---|
Born | |
Citizenship | United States |
Alma mater | Mount Union College Case Western Reserve University |
Known for | Co-invention of an implantable artificial kidney, medical MEMS |
Scientific career | |
Fields | Bioengineering, Biomedical MEMS, Pediatric Devices |
Institutions | University of California, San Francisco |
Doctoral advisor | Mehran Mehregany |
Shuvo Roy is a Bangladeshi American biomedical engineer known for his work with Bio-MEMS including the invention of an artificial kidney. [1] He currently serves as a professor at the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.
Shuvo Roy was born on 10 November 1969 in Dhaka (now in Bangladesh) to Asoke Nath Roy, a public health physician, and Ratna Roy, a teacher. His grandfather Nagen Dey was a professor of English at Sir Ashutosh Mukherjee College, Boalkhali. He hails from Chittagong Division, his paternal family being from Rosangiri in Fatikchhari and his maternal family being from Alkaran Ward. [2]
Roy started his elementary education in Siddheswari in Dhaka but moved with his father, mother and siblings to Uganda in 1974 where he received most of his education including at the Jinja Senior Secondary School (his mother being employed at the institution). [1]
Roy obtained a scholarship to go to the United States and earn his BS degree from University of Mount Union, Ohio in 1992, where he majored in Physics, Mathematics, and Computer Science. He then earned his MS degree in Electrical Engineering and Applied Physics from Case Western Reserve University in Cleveland, Ohio in 1995. He went on to earn his PhD degree in Electrical Engineering and Computer Science from the same school in 2001. [3]
Roy has developed silicon nanopore membranes (SNM) to achieve high-efficiency blood ultrafiltration while selectively retaining specific solutes and serving as an immunoprotective barrier for encapsulated cells. The SNM are the fundamental underlying technology for the development of an implantable bioartificial kidney. [4]
Using this technology, he has shown feasibility for an implantable bioartificial pancreas (iBAP). Previous attempts to develop a bioartificial pancreas have been severely limited by insufficient mass transfer and a limited supply of beta cells, but Roy says that ultra-high hydraulic permeability characteristic of the SNM will enable appropriate mass transport (especially oxygen, glucose, and insulin) to achieve optimal beta cell performance, while the ultra-selective pore characteristic of the SNM enable unprecedented immunoisolation. Also, the iBAP can utilize a human stem cell derived fully functional beta cell that provides and unlimited supply of beta cells. [5]
He is a founding member of the University of California, San Francisco Pediatric Device Consortium. [3]
![]() |